Disease-modifying drugs for Alzheimer's: hope or hype? New Alzheimer's drugs are now in clinical trials. Experts advise cautious optimism.
D000544:Alzheimer Disease / Q000517:prevention & control*; D053829:Amyloid Precursor Protein Secretases / Q000037:antagonists & inhibitors; D016229:Amyloid beta-Peptides / Q000096:biosynthesis / Q000187:drug effects; D015195:Drug Design; D004347:Drug Interactions; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D006801:Humans; D018697:Nootropic Agents / Q000009:adverse effects / Q000627:therapeutic use*; D019338:Polypharmacy
D016229:Amyloid beta-Peptides; D004791:Enzyme Inhibitors; D018697:Nootropic Agents; D053829:Amyloid Precursor Protein Secretases